According to Wedbush, OmniVision Technologies OVTI price target is lowered to $38.
Wedbush said that it reiterates its OUTPERFORM rating on OmniVision (OVTI), and it is reducing its PT to $38 from $45 largely on multiple compression and a modest change to the estimates ahead of the company's FQ1 (Jul) results set to be reported AMC on Thursday, August 25. “Reiterate OUTPERFORM and reducing PT to $38. Our new 12-month PT of $38 from $45 is based upon about 10x (from 12x) our CY:12 pro forma EPS estimate of $3.05 (from $3.14), plus $7.59 in cash per share.”
OmniVision Technologies closed yesterday at $26.01.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in